Platelet P2Y12 receptor antagonist pharmacokinetics and pharmaco -dynamics: A foundation for distinguishing mechanisms of bleeding and anticipated risk for platelet-directed therapies
Richard C. Becker
1
Duke University School of Medicine, Durham, North Carolina, United States
,
Paul A. Gurbel
2
Sinai Center for Thrombosis Research, Baltimore, Maryland, United States